JP Patent

JP7214632B2 — ブルトン型チロシンキナーゼ阻害剤のコハク酸塩形態および組成物

Assigned to Biogen MA Inc · Expires 2023-01-30 · 3y expired

What this patent protects

Patent listed against Imbruvica.

Drugs covered by this patent

Patent Metadata

Patent number
JP7214632B2
Jurisdiction
JP
Classification
—
Expires
2023-01-30
Drug substance claim
No
Drug product claim
No
Assignee
Biogen MA Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.